Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Intimation ....
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals Ltd has informed the BSE that a meeting of its Board of Directors is scheduled for Friday, 30th May 2025, at the company's registered office in Indore. The main agenda is to consider and approve the Audited Financial Results of the company for the fourth quarter as well as the full financial year ended on 31st March 2025, along with the Auditor's Report. The filing has been made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The company has also reminded that the trading window for dealing in its securities remains closed for designated persons, their immediate relatives, and connected persons, and will reopen 48 hours after the audited results are declared.
This is a routine compliance filing that signals the upcoming release of Q4 and full-year FY25 audited results on 30th May 2025. Investors should watch the results announcement closely as it will be the key driver for any short-term stock movement. The trading window closure is standard procedure and not a cause for concern.